SMA News TodayAveXis Presents Promising Clinical Trial Results of Gene Therapy for Type 1 SMASMA News TodayThe pharmaceutical company AveXis recently presented the latest data about its clinical trial for AVXS-101, a gene therapy for infants with type … Continue reading
|
GSK partners with Bluebird to commercialise gene therapies
Life Sciences Intellectual Property Review (subscription) GSK and biotech company Bluebird Bio have entered into a licence agreement centring on Bluebird’s lentiviral vector platform. Lentiviral vectors are used as tools for gene delivery in mammalian cells. As part of the agreement, GSK will be given a … |
Slate Magazine |
How the U.S. Military’s Synthetic Biology Initiatives Could Change the Entire Research Field
Slate Magazine In recent years, however, the military—mostly under the umbrella of the Defense Advanced Research Projects Agency—has created a new suite of programs that take a very different approach to harnessing the power of nature: synthetic biology. Among … |
The Sun |
Bradley Lowery ‘feeling better’ as he undergoes T-Cell treatment trial in London
The Sun BRAVE Bradley Lowery is “feeling better” as he undergoes immunotherapy treatment a week after being in “horrendous pain”. The ill tot, who is battling neuroblastoma, was forced to cancel his appearance as Sunderland’s mascot last week amid fears his … |